Le Lézard
Classified in: Health
Subject: FDA

U.S. Food & Drug Administration Approves New Wet Age-Related Macular Degeneration Treatment

WEST DES MOINES, Iowa, Oct. 22, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) announced approval on October 8, 2019 of Novartis's Beovu® (brolucizumab), a vascular endothelial growth factor inhibitor that may reduce the frequency of intravitreal injections for patients suffering from wet age-related macular degeneration (AMD). Wolfe Eye Clinic was an active site in the Novartis phase three clinical trial program leading up to the FDA approval of Beovu. This highly anticipated approval is the first major breakthrough in wet AMD treatment since the approval of Eylea (Aflibercept) in 2011.

(PRNewsfoto/Wolfe Eye Clinic)

"We are excited to have Beovu as a new option for patients who suffer from Wet AMD to help preserve vision reducing the burden of treatment," said Jared Nielsen, MD, MBA, HAWK Trial Principal Investigator, Retina Specialist and Director of Retina Clinical Trials at Wolfe Eye Clinic, "this extends to friends and family who assist them in their care."

According to the Centers for Disease Control and Prevention, Wet AMD is a leading cause of severe vision loss and blindness worldwide in adults over 65. It is estimated that over 1.5 million people in the United States will have wet AMD by 2020 according to Novartis's recent release. Wet AMD is a disease associated with age that attacks the part of the eye called the macula responsible for our central vision and the ability to see fine details. Living with the disease can make everyday tasks difficult, if not impossible, such as reading, driving and identifying faces. Individuals affected often rely on others for daily assistance. If left untreated, vision may rapidly deteriorate.

Until now, treatment for wet AMD consisted of drug injections (e.g., Eylea) into the eye as frequent as every month. Many patients require frequent eye injections in order to prevent permanent vision loss. Clinical trials indicate that in comparison to Eylea, another intravitreal injection drug option, Beovu may allow patients to go as long as three months between injections. 

In medical practice since 1919, Wolfe Eye Clinic is a recognized regional diagnostic and surgical center offering a broad range of ophthalmology care services. Wolfe Eye Clinic has 49 doctors providing patient care in over 40 communities throughout Iowa including their main offices in Ames, Cedar Falls, Cedar Rapids, Fort Dodge, Iowa City, Marshalltown, Ottumwa, Pleasant Hill, Spencer, Waterloo and West Des Moines.

Wolfe Eye Clinic surgeons have specialized fellowship training in the areas of cataract and refractive surgery, cornea and external disease, glaucoma, pediatric ophthalmology and adult strabismus, oculoplastics, and medical and surgical retina. Wolfe Eye Clinic is a national leader in the advancement of new treatments for sight threatening retinal diseases. The clinic is currently engaged in over 15 protocols working to develop better therapies for people who suffer from age-related macular degeneration and diabetic retinopathy.

For Press Inquiries: Kassandra Trenary        641.754.6200              ktrenary@wolfeclinic.com

SOURCE Wolfe Eye Clinic

These press releases may also interest you

at 11:05
SCIEX, a global leader in life science analytical technologies, launches the next generation of its flagship nominal mass spectrometer, the SCIEX Triple Quadtm 7500 LC-MS/MS System ? QTRAP® Ready. This system delivers the highest level of sensitivity...

at 11:05
SCIEX, a global leader in life science analytical technologies, introduces the fully integrated SCIEX OS Software, the core engine running SCIEX innovations. Today, SCIEX OS Software becomes available on the Echo® MS System and the SCIEX Triple...

at 11:00
Steel Guard Safety Corp, a leading manufacturer of industrial curtain and specialty barrier products, announced the release of Personal Safety Partition for use in restaurants, checkout counters, medical offices and any business area that need...

at 11:00
Binah.ai, the leading provider of general health and wellness video-based monitoring tools powered by artificial intelligence (AI), today announced that it is the recipient of two 2020 Future Digital Awards, Best Digital Health Innovation and...

at 11:00
The latest data of the evolution of COVID-19 in Québec reveal 137 new cases over the past 24 hours, bringing the total number of people infected to 56,216. During the same period, 2 new deaths were recorded, to which are added 4 deaths that occurred...

at 11:00
Innovation, Science and Economic Development Canada The Honourable Navdeep Bains, Minister of Innovation, Science and Industry, and the Honourable Anita Anand, Minister of Public Services and Procurement, will be at GM Canada's Oshawa Operations...

News published on 22 october 2019 at 12:27 and distributed by: